The HEPAMAP is an advocacy tool:
(1) for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda and also;
(2) to raise awareness more generally of liver disease and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.
You are invited to join EASL on December 10, 2014 at the European Parliament, Brussels, Belgium, for the launch of the research roadmap for liver disease.
Click here for more HEPAMAP information.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter